About this trial
Early extubation in ICU patients is crucial for reducing complications of prolonged ventilation, including morbidity and mortality. The Rapid Shallow Breathing Index (RSBI) is a widely used predictor for weaning patients from mechanical ventilation. This study aims to determine the predictive value of RSBI measurements for extubation success in mechanically ventilated ICU patients
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
• Adults > 22 years.
FiO₂ ≤ 0.4, PEEP ≤ 8 cmH₂O, PaO₂/FiO₂ ≥ 200 mmHg.
Respiratory rate ≤ 35 breaths/min, pH > 7.30.
Hemodynamic stability (HR ≤ 120 bpm, SBP 90-160 mmHg).
Disqualifiers
Age <22 years.
Refusal of informed consent.
Altered mental status (e.g., traumatic brain injury).
Hemodynamic instability or deep sedation (RASS ≤ -2).
Trial population
mechnically ventilated patient eligable for extubation
Trial design
Case-only
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Extubation success (no reintubation/adjuvant support within 48h).
no reintubation or adjuvant oxygen therapy
Sponsors and contacts
Click on the lead sponsor to view all of their trials.